ea0077op4.4 | Metabolism, Obesity and Diabetes | SFEBES2021
Narendranathan Divani
, Richards Molly
, Cassin-Scott Rebecca
, Chia Eng Pei
, Distaso Walter
, Tan Tricia
, Izzy-Engbeaya Chioma
, Salem Victoria
Background: Dexamethasone significantly improved outcomes in patients requiring supplementary oxygen and in ventilated patients with COVID-19 in the RECOVERY trial. Consequently, dexamethasone is now routinely used in these patients. However, dysglycaemia is commonly associated with steroid use and is an established risk factor for poorer outcomes in COVID-19. In this study, we aimed to elucidate the effect of dexamethasone use in patients hospitalised with COVID-19 in a real-...